The impact of COVID-19 pandemic on psoriasis patients in northern Greece
Dermatol Ther
.
2022 Feb;35(2):e15244.
doi: 10.1111/dth.15244.
Epub 2021 Dec 10.
Authors
Zoe Apalla
1
,
Christina Fotiadou
1
,
Anastasia Emvalomati
1
,
Aikaterini Patsatsi
1
,
Myrto Trakatelli
1
,
Anastasia Trigoni
1
,
Athanassios Kyrgidis
2
,
Christina Trakatelli
3
,
Georgios Papazisis
4
,
Aimilios Lallas
5
,
Ourania Droggoula
1
,
Melpomeni-Maria Giannakaki
1
,
Valentina Oflidou
1
,
Styliani Siskou
1
,
Maria Boziou
1
,
Kalliopi Karydi
1
,
Athena Daponte
1
,
Christina Kemanetzi
1
,
Fragkiski Tsatsou
1
,
Eirini Kyrmanidou
1
,
Elizabeth Lazaridou
1
Affiliations
1
Second Dermatology Department, Faculty of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece.
2
Maxillofacial Surgery Department, Papanikolaou General Hospital of Thessaloniki, Greece.
3
Department of Internal Medicine, Faculty of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece.
4
Pharmacology Laboratory, Faculty of Medicine, Aristotle University, Thessaloniki, Greece.
5
First Dermatology Department, Faculty of Medicine, Aristotle University, Hospital of Skin and Venereal Diseases, Thessaloniki, Greece.
PMID:
34862701
DOI:
10.1111/dth.15244
No abstract available
Publication types
Letter
MeSH terms
COVID-19*
Greece / epidemiology
Humans
Pandemics
Psoriasis* / diagnosis
Psoriasis* / epidemiology
SARS-CoV-2